Fulgent Genetics (FLGT) Non-Current Deferred Tax Liability (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Non-Current Deferred Tax Liability for 6 consecutive years, with $6.9 million as the latest value for Q4 2025.
- Quarterly Non-Current Deferred Tax Liability rose 8.89% to $6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Dec 2025, up 8.89% year-over-year, with the annual reading at $6.9 million for FY2025, 8.89% up from the prior year.
- Non-Current Deferred Tax Liability hit $6.9 million in Q4 2025 for Fulgent Genetics, down from $7.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $9.8 million in Q3 2023 to a low of $6.1 million in Q2 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $7.2 million across 3 years, with a median of $6.9 million in 2024.
- Biggest five-year swings in Non-Current Deferred Tax Liability: crashed 31.52% in 2024 and later grew 8.89% in 2025.
- Year by year, Non-Current Deferred Tax Liability stood at $8.0 million in 2023, then fell by 19.99% to $6.4 million in 2024, then grew by 8.89% to $6.9 million in 2025.
- Business Quant data shows Non-Current Deferred Tax Liability for FLGT at $6.9 million in Q4 2025, $7.0 million in Q3 2025, and $6.1 million in Q2 2025.